Appointed
Mark Frissora
Board of Directors
BDPT ·
BIOADAPTIVES, INC.
On February 3, 2025 , the Company appointed Mr. Mark Frissora to its Board of Directors.
Ready 8-Ks
15
Latest filing
March 18, 2025, 7:59 PM ET
Top materiality
0.70
Event mix
other_material ×10 · leadership ×2 · dividend ×1
Sentiment
7 pos · 1 neg · 7 neu
Executive change
recent →
Recent 8-K filings for BDPT
Highest-materiality recent filing
BioAdaptives appoints James Keener as new CEO and Chairman; Jacobs and Ellis resign
- Edward Jacobs resigned as Chairman and CEO; Robert Ellis resigned as director and President, both for personal reasons.
- James Keener elected Chairman of the Board and appointed CEO, becoming sole officer and board member.
-
BioAdaptives gets IRB approval for human trial of weight management product Zeranovia
IRB approved human clinical trial for Zeranovia, a weight management supplement.
-
BioAdaptives completes 1-for-300 reverse stock split effective Nov 21, 2024
Reverse split reduces outstanding shares from ~1.23B to ~4.1M.
-
BioAdaptives appoints James Keener as new CEO and Chairman; Jacobs and Ellis resign
Edward Jacobs resigned as Chairman and CEO; Robert Ellis resigned as director and President, both for personal reasons.
-
SEC permanently suspended BF Borgers from practicing as accountants and PCAOB auditors on SEC filings, effective May 3, 2024.
-
BioAdaptives acquires exclusive option to buy oxygenated-water patent, forms MORO2 subsidiary
Exclusive two-year option to purchase U.S. Patent 9,783,432B for $400,000.
Executive changes
Appointed
Reed Harris
Advisory Board
BDPT ·
BIOADAPTIVES, INC.
On February 6, 2025, the Company appointed Mr. Reed Harris to its Advisory Board.
Appointed
Dr. Yaguang Liu
Board of Directors
BDPT ·
BIOADAPTIVES, INC.
On April 5, 2023, the Company appointed Dr. Yaguang Liu to its Board of Directors.
Materiality & sentiment trend
Max materiality 0.70 · Median 0.55 · Most common event other_material